Kui Mei

Title: Innovations by Kui Mei in Camptothecin Derivatives

Introduction

Kui Mei is an accomplished inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly in the synthesis of camptothecin derivatives. His work focuses on developing efficient methods for producing compounds that have potential therapeutic applications.

Latest Patents

Kui Mei holds a patent for an "Intermediate for synthesizing camptothecin derivative, preparation method therefor, and use thereof." This patent describes an innovative intermediate A that can be synthesized from 3-fluoro-4-methylaniline through a series of reactions including acylation, bromination, and cross-coupling. The intermediate A is crucial for preparing intermediate B, which can further lead to the production of exatecan mesylate. The described methods are notable for their low-cost starting materials, moderate reaction conditions, and high yields, making them suitable for industrial production.

Career Highlights

Kui Mei is currently employed at Shanghai Haoyuan Medchemexpress Co., Ltd. His work at this company has allowed him to focus on the development of pharmaceutical intermediates and contribute to advancements in drug synthesis.

Collaborations

He collaborates with talented coworkers, including Tao Ma and Bao Fu Zheng, who share his commitment to innovation in the field of medicinal chemistry.

Conclusion

Kui Mei's contributions to the synthesis of camptothecin derivatives highlight his role as a key innovator in medicinal chemistry. His patent reflects a significant advancement in the field, showcasing his expertise and dedication to developing efficient and cost-effective methods for drug production.